Chromosome translocations in multiple myeloma
The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Abstract
Multiple myeloma (MM), a malignant tumor of somatically mutated, isotype-switched plasma cells (PC), usually arises from a common benign PC tumor called Monoclonal Gammopathy of Undetermined Significance (MGUS). MM progresses within the bone marrow, and then to an extramedullary stage from which MM cell lines are generated. The incidence of IgH translocations increases with the stage of disease: 50% in MGUS, 60-65% in intramedullarly MM, 70-80% in extramedullary MM, and >90% in MM cell lines. Primary, simple reciprocal IgH translocations, which are present in both MGUS and MM, involve many partners and provide an early immortalizing event. Four chromosomal partners appear to account for the majority of primary IgH translocations: 11q13 (cyclin D1), 6p21 (cyclin D3), 4p16 (FGFR3 and MMSET), and 16q23 (c-maf). They are mediated primarily by errors in IgH switch recombination and less often by errors in somatic hypermutation, with the former dissociating the intronic and 3' enhancer(s), so that potential oncogenes can be dysregulated on each derivative chromosome (e.g., FGFR3 on der14 and MMSET on der4). Secondary translocations, which sometimes do not involve Ig loci, are more complex, and are not mediated by errors in B cell specific DNA modification mechanisms. They involve other chromosomal partners, notably 8q24 (c-myc), and are associated with tumor progression. Consistent with MM being the malignant counterpart of a long-lived PC, oncogenes dysregulated by primary IgH translocations in MM do not appear to confer an anti-apoptotic effect, but instead increase proliferation and/or inhibit differentiation. The fact that so many different primary transforming events give rise to tumors with the same phenotype suggests that there is only a single fate available for the transformed cell.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Approximately 40% of multiple myeloma is characterized by the presence of trisomies in the neoplastic plasma cells (hyperdiploid multiple myeloma), while most of the rest have a translocation involving the immunoglobulin heavy chain (IgH) locus on chromosome 14q32 (IgH translocated multiple myeloma).38–41”
From Multiple myeloma: 2024 update on diagnosis, risk-stratification, and management (2024) · cites this paper as [39]
Citations
Cites
SEER Cancer Statistics Review, 1975-2003
Ries, L. A. G., Harkins, D., Krapcho, M. F., Mariotto, A. B., Miller, B., Feuer, E. J., Clegg, L. X., Eisner, M. P., Horner, M., Howlader, N., et al. (2006) · Digital Archive @ GSU · Cited by 11,774
Cancer: Principles and Practice of Oncology.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-819_4 · Cited by 8,516
Cancer: Principles and Practice of Oncology.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-506_5 · Cited by 1,900
Dalla-Favera, R., Bregni, M., Erikson, J., Patterson, D., Gallo, R. C., & Croce, C. M. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.24.7824 · Cited by 1,773
Anderson, P. C. (1999) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.281.24.2351 · Cited by 1,006
Cellular Origin of Human B-Cell Lymphomas
Küppers, R., Klein, U., Hansmann, M.-L., & Rajewsky, K. (1999) · New England Journal of Medicine · doi:10.1056/nejm199911113412007 · Cited by 715
The Proto-Oncogene c-maf Is Responsible for Tissue-Specific Expression of Interleukin-4
Ho, I.-C., Hodge, M. R., Rooney, J. W., & Glimcher, L. H. (1996) · Cell · doi:10.1016/s0092-8674(00)81299-4 · Cited by 667
Chesi, M., Nardini, E., Brents, L. A., Schröck, E., Ried, T., Kuehl, W. M., & Bergsagel, P. L. (1997) · Nature Genetics · doi:10.1038/ng0797-260 · Cited by 637 · cited 2×
“…of conventional cytogenetics, SKY analyses, metaphase FISH analyses, isolation of molecular clones, and RT±PCR assays (Bergsagel et al., 1996; Chesi et al., 1997, 1998a; Gabrea et al., 1999; Shaughnessy et al., 2001; Shou et al., 2000; Kuehl, 2001, unpublished results), we have identi®ed at…”
BackgroundSelf-citationChesi, M., Nardini, E., Lim, R. S. C., Smith, K. D., Kuehl, W. M., & Bergsagel, P. L. (1998) · Blood · doi:10.1182/blood.v92.9.3025 · Cited by 572
Self-citationDNA repair protein Ku80 suppresses chromosomal aberrations and malignant transformation
Difilippantonio, M. J., Zhu, J., Chen, H. T., Meffre, E., Nussenzweig, M. C., Max, E. E., Ried, T., & Nussenzweig, A. (2000) · Nature · doi:10.1038/35006670 · Cited by 547
Research works printed but not linked: 1
- Ries LAG, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg L, Edwards BK . 2000 SEER Cancer Statistics Review, 1973–1997 National Cancer Institute: Bethesda
Cited by
Items 401–500 of 545
Complex cytogenetic research of cryptic chromosomal aberrations in patients with multiple myeloma
Солодовник, А. А., Mkrtchian, A. S., Misyurin, V. A., Кесаева, Л. А., Касаткина, Н. Н., Votyakova, O. M., Юрьевна, Я. О., Medvedovskaya, E. G., Антипова, А. С., Заводнова, И. З., et al. (2019) · Russian Journal of Biotherapy · doi:10.17650/1726-9784-2019-18-1-50-59 · Cited by 1
The Molecular Biology of Multiple Myeloma
Chng, W. J., & Bergsagel, P. L. (2010) · Wiley eBooks · doi:10.1002/9781444318531.ch11 · Cited by 1
Self-citationKrishnan, A. Y., Nathwani, N., Amanam, I. U., & Gupta, R. (2019) · Springer eBooks · doi:10.1007/978-3-030-31471-2_5 · Cited by 1
Evidence for ABL Amplification in Multiple Myeloma and Therapeutic Implications
Huang, H. F., Zhou, S., Lin, H., Guo, W., Lin, Y., Yao, R., He, L., Yu, K., & Li, Q. (2022) · Journal of Oncology · doi:10.1155/2022/4112016 · Cited by 1
Öner, A. O., Özdemir, Ç., Yavaşoğlu, F., Şenol, Y., & Adsız, S. N. (2023) · Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) · doi:10.1016/j.remnie.2023.03.002 · Cited by 1
Cytogenetic Abnormalities in Multiple Myeloma: The Importance of FISH and Cytogenetics
Braggio, E., Sébag, M., & Fonseca, R. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-564-0_5 · Cited by 1
Dachs, L. R. (2006) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) · Cited by 1
Leukemias and Lymphomas: Genetics
Look, A. T., & Ferrando, A. A. (2006) · Wiley eBooks · doi:10.1038/npg.els.0005553 · Cited by 1
Cytogenetics of Leukaemia and Lymphoma
Harrison, C. J. (2005) · Wiley eBooks · doi:10.1002/9780470987056.ch30 · Cited by 1
Signaling, Drugs and Apoptosis of Myeloma Cells
Carroll, M. P., & Abrams, C. S. (2004) · Cancer Biology & Therapy · doi:10.4161/cbt.3.2.739 · Cited by 1
Taniguchi, I., Hata, H., & Sonoki, T. (2005) · Journal of the Japan Society of the Reticuloendothelial System · doi:10.3960/jslrt.45.81 · Cited by 1
Classification and Characteristics of Mouse B Cell—Lineage Lymphomas
Morse, H. C. (2004) · Elsevier eBooks · doi:10.1016/b978-012053641-2/50025-3 · Cited by 1
LAZZARI, E. (2015) · Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) · doi:10.13130/e-lazzari_phd2015-12-17 · Cited by 1
Enhancement of death receptor-mediated apoptosis in multiple myeloma cells
Arhoma, A. A. (2017) · Sheffield Hallam University · doi:10.7190/shu-thesis-00026 · Cited by 1
Examining telomere dysfunction in multiple myeloma
Hyatt, S. (2017) · ORCA Online Research @Cardiff (Cardiff University) · Cited by 1
Liberati, S. (2014) · IRIS Research product catalog (Sapienza University of Rome) · Cited by 1
Dissecting aberrant proteolytic ubiquitin networks in cancer
Richter, C. G. (2020) · Cited by 1
Plasma Cell Myeloma and Other Plasma Cell Dyscrasias
Yared, M. A. (2009) · Humana Press eBooks · doi:10.1007/978-1-60761-384-8_19 · Cited by 1
The Use of Bortezomib in Autologous Transplantation for Multiple Myeloma
Langston, A. A., & Lonial, S. (2010) · Springer eBooks · doi:10.1007/978-3-7643-8948-2_5
Fibroblast Growth Factor Receptor 3 and Multiple Myeloma
Jimenez-Zepeda, V. H., & Stewart, A. K. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-564-0_23
The tumor microenvironment is critical for the development of plasma cell neoplasia in mice
Rosean, T. R., Janz, S., Waldschmidt, T. J., Goel, A., Colgan, J. D., & Bishop, G. A. (2014) · doi:10.17077/etd.4zfhrfac
Pharmacogenetic studies in multiple myeloma
Corthals, S. L. (2011) · RePub (Erasmus University Rotterdam)
Cellular Basis of Antibody Maintenance: Heterogeneity of the Bone Marrow Plasma Cell Pool
Chernova, I. (2013) · ScholarlyCommons (University of Pennsylvania)
Immunoglobulin gene alterations in the progression of B cell lymphomas
Smit, L. A. (2008) · UvA-DARE (University of Amsterdam)
STAGING AND RISK-STRATIFICATION OF MULTIPLE MYELOMA
Stewart, A. K. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9780511551901.002
Cell cycle regulation and myeloma precursor cells
Quinn, J., & Yong, K. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9780511862465.004
Rajkumar, S. V., & Hayman, S. R. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511781926.010
Kocemba‐Pilarczyk, K. A. (2014) · UvA-DARE (University of Amsterdam)
Genetic Analyses of Multiple Myeloma and Related Plasma Cell Dyscrasias
Nilsson, T. (2004) · Lund University Publications (Lund University)
Untersuchungen zur Rolle der Rac1-GTPase für die Entwicklung und Funktion von B-Lymphozyten
Nopora, A. (2005) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.7758
Caracterización genética y genómica del mieloma múltiple
Iglesias, C. L. (2007) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Janz, M. (2014) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-17738
Tsai, K. Y. (2005) · Archives of Dermatology · doi:10.1001/archderm.141.11.1468-b
Hepatocyte growth factor, c-Met and syndecan-1 in multiple myeloma
Wader, K. F. (2011) · NORA - Norwegian Open Research Archives
Routine laboratory diagnosis of chromosome aberrations in multiple myeloma
Chin, Y. M., & Zakaria, Z. (2014) · International Journal of Research in Medical Sciences · doi:10.5455/2320-6012.ijrms20141108
Myeloma: A malignant disorder of bone and soft tissue
Mankin, H. J., Mankin, K. P., & Harmon, D. C. (2014) · Journal of Solid Tumors · doi:10.5430/jst.v4n2p36
Groen, R. W. J. (2002) · UvA-DARE (University of Amsterdam)
Clinical Significance of Cytogenetics in Multiple Myeloma and Chronic Lymphocytic Leukemia
Shah, J., Kukunoor, R., Theil, K. S., & Kalaycio, M. E. (2004) · Laboratory Medicine · doi:10.1309/qu40uca620vlxm9f
Menoni-Blanco, B. J., & Abreu, A. J. D. S.-D. (2010)
Kurb, N. (2012) · OPen Access Repositorium der Universität Ulm (OPARU) (Ulm University) · doi:10.18725/oparu-2832
Schwarzwälder, P. (2014) · OPen Access Repositorium der Universität Ulm (OPARU) (Ulm University) · doi:10.18725/oparu-3433
Gammapatía monoclonal de significado incierto asociada con neuropatía periférica
Morales-Hernández, A. E., Rojas, L. V., & Hernández-Salcedo, D. R. (2016) · Medicina Interna de México
Molecular Pathology of Hematological Malignancies
Killeen, A. A. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-431-3_8
Gorczyca, W., & Emmons, F. N. (2008) · CRC Press eBooks · doi:10.3109/9781439806487-14
Multiple Myeloma : an update on disease biology and therapy
Dingli, D., & Cook, R. J. (2004) · OAR@UM (University of Malta)
Inhibiting Translation as a Novel Strategy to Target Multiple Myeloma
Roman, W., Cencic, R., Huang, X.-F., Porco, J. A. J., Pelletier, J., Shustik, C., & Sébag, M. (2010) · Blood · doi:10.1182/blood.v116.21.2995.2995
Article title: Gene Mapping and Expression Analysis of 16q Loss of Heterozygosity Identifies
Jenner, M. W., Leone, P., Walker, B. A., Ross, F. M., Johnson, D. C., González, D., Chiecchio, L., Cabanas, E. D., Dagrada, G. P., Stockley, D., et al. (2016)
Cytogenetics of Plasma Cell Neoplasms
Sawyer, J. R. (2016) · Springer eBooks · doi:10.1007/978-3-319-42370-8_4
Kuehl, W. M., & Bergsagel, P. L. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139046947.075
Self-citationSilencing Immunoglobulin Gene Enhancers as a Potential Treatment Strategy for Multiple Myeloma
Toman, I., Loree, J. M., Duerksen, K., Evans, R. P., & Reiman, T. (2008) · Blood · doi:10.1182/blood.v112.11.5162.5162
Etude des évènements génétiques associés à l'évolution du myélome multiple avec t(4;14)
Song, X. Y. (2017) · theses.fr (ABES) · doi:10.70675/be8801c8z32d9z4868z916czce50900b725b
IFN-Gamma-Mediated Immunoevasive Strategies in Multiple Myeloma
Ciarlariello, P. D. (2016) · OhioLink ETD Center (Ohio Library and Information Network)
Bedeutung von Cyclin D1 mRNA Varianten beim multiplen Myelom
Slotta-Huspenina, B. J. (2010) · mediaTUM (Technical University of Munich)
Influence of microRNA on Resistance to Proteasome Inhibitors in Multiple Myeloma
Degelman, E. (2012) · Libraries and Cultural Resources (University of Calgary) · doi:10.11575/prism/18414
Changes in protein profiles in Bortezomib applied Multiple Myeloma cells
Turan, T. (2011) · İYTE (İZMİR YÜKSEK TEKNOLOJİ ENSTİTÜSÜ)
Therapeutic Targets and Signaling Pathways for Diagnosis of Myeloma
Ahmed, Z. A., Nasir, A., Shaikh, M. S., Moatter, T., & Rasheed, A. A. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.81751
Ye, Q. (2018) · OhioLink ETD Center (Ohio Library and Information Network)
Adesanya, M. A. (2018) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Heredia, Y. (2019) · Docta Complutense (Universidad Complutense de Madrid)
Meckbach, C. (2019) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-7595
A genotypic, phenotypic and functional exploration of multiple myeloma sub-clones
Murray, J. W. (2019) · ORCA Online Research @Cardiff (Cardiff University)
Prevalencia de patología periapical en dientes endodonciados de pacientes con mieloma múltiple
Díaz, S. P. (2019) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Investigating the Role of CD45 in the Pathogenesis and Disease Progression in Multiple Myeloma
Man, W. Y. (2020) · Figshare · doi:10.26180/11521671
Entwicklung neuer Diagnostikmethoden für genetische Erkrankungen basierend auf der Click-Chemie
Raddaoui, N. (2019) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.26374
Mechanisms of sensitization to apoptosis in multiple myeloma.
Hammarberg, A. (2007) · Uppsala University Publications (Uppsala University)
Multipl Myelom Tanılı Hastaların Sitogenetik Özellikleri ve Prognoza Etkisi
Kars, T. U., Tekinalp, A., Dikici, H. Z., Demircioğlu, S., & Çeneli, Ö. (2020) · LLM Dergi · doi:10.5578/llm.20219902
Funktionelle Charakterisierung des Ras family small GTP binding protein RAL im Multiplen Myelom
Seibold, M. (2020) · Online Publication Service of Würzburg University (Würzburg University) · doi:10.25972/opus-20800
GENOMIC LANDSCAPE AND TRANSCRIPTIONAL REGULATION BY YAP AND MYC IN THE LIVER
Croci, O. (2018) · Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) · doi:10.13130/croci-ottavio_phd2018-03-26
Pathogenesis of Multiple Myeloma
Chesi, M., & Bergsagel, P. L. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8520-9_4
Self-citationRole and regulation of the heat shock proteins Hsp90 alpha and beta in Multiple Myeloma
Jain, S. (2008) · edoc Publication server (Humboldt University of Berlin) · doi:10.18452/15809
(2021) · Wiley eBooks · doi:10.1002/9781119611288.refs
Ahmed, A. (2022) · Annals of International medical and Dental Research · doi:10.53339/aimdr.2022.8.1.29
Monoclonal Gammopathies of Undetermined Significance and Smoldering Multiple Myeloma
Lust, J. A., Jelinek, D. F., & Donovan, K. A. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8520-9_7
Differential diagnosis – chromosomal/molecular changes
Gorczyca, W., & Emmons, F. N. (2008) · CRC Press eBooks · doi:10.3109/9781439806487-16
Ortolani, C. (2011) · Wiley eBooks · doi:10.1002/9781444398069.ch2
Hematopoietic Cell Transplantation for Multiple Myeloma
Krishnan, A. Y., & Giralt, S. (2015) · Wiley eBooks · doi:10.1002/9781118416426.ch55
(2003) · Elsevier eBooks · doi:10.1016/b978-012639881-6/50011-7
Hematologic malignancies: correlation between morphology, phenotype,
Gorczyca, W. (2008) · CRC Press eBooks · doi:10.3109/9780203091555-6
(2011) · Springer eBooks · doi:10.1007/springerreference_39156
Targeting α4 Integrin Containing Complexes in Multiple Myeloma Using Peptidomimetics
Emmons, M. F. (2012) · Digital Commons - University of South Florida (University of South Florida)
Myelodysplastic Syndromes and Chronic Myeloproliferative Neoplasms
Gorczyca, W. (2010) · CRC Press eBooks · doi:10.3109/9781841847443-16
Hayman, S. R. (2004) · Springer eBooks · doi:10.1007/978-3-662-08885-2_5
Shain, K. H., & Dalton, W. S. (2007) · Humana Press eBooks · doi:10.1007/978-1-59259-963-9_83
Yee, A. J., Hideshima, T., Raje, N. S., & Anderson, K. C. (2022) · Wiley eBooks · doi:10.1002/9781119000822.hfcm122.pub2
Arani, Z. S., Hajjari, M., Asl, J. M., & Saki, N. (2023) · Gene Cell and Tissue · doi:10.5812/gct-131389
Data from G-Rich Proto-Oncogenes Are Targeted for Genomic Instability in B-Cell Lymphomas
Duquette, M. L., Huber, M. D., & Maizels, N. (2023) · doi:10.1158/0008-5472.c.6494915
Data from G-Rich Proto-Oncogenes Are Targeted for Genomic Instability in B-Cell Lymphomas
Duquette, M. L., Huber, M. D., & Maizels, N. (2023) · doi:10.1158/0008-5472.c.6494915.v1
Metadata
- Authors
- Bergsagel, P. L., & Kuehl, W. M.
- Affiliations
- Cornell University (US)
- National Cancer Institute (US)
- Corresponding author
- Bergsagel, P Leif
- ORCID
- Bergsagel, P Leif
- Venue
- Oncogene
- Published
- 2001-09-10
- Volume
- 20
- Issue
- 40
- Pages
- 5611-5622
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W1977707370
- Cited by
- 478
- References
- 64
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 7 · 2023: 16 · 2022: 17 · 2021: 16 · 2020: 13 · 2019: 12 · 2018: 11 · 2017: 15 · 2016: 17 · 2015: 21 · 2014: 16 · 2013: 26 · 2012: 19
- FWCI
- 4.12
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Multiple Myeloma Research and Treatments
- Health Sciences › Medicine › Hematology › Chronic Lymphocytic Leukemia Research
- Health Sciences › Medicine › Pathology and Forensic Medicine › Lymphoma Diagnosis and Treatment
- Keywords
- multiple myeloma, chromosomal translocation, immunoglobulin heavy chain locus, monoclonal gammopathy of undetermined significance, cyclin D1, cyclin D3, FGFR3, MMSET, c-Maf, c-Myc, somatic hypermutation, tumor progression, extramedullary myeloma
- MeSH terms
- Cell Line, Transformed, Chromosomes, Chromosomes, Human, Pair 11, Chromosomes, Human, Pair 16, Chromosomes, Human, Pair 4, Chromosomes, Human, Pair 6, Chromosomes, Human, Pair 8, Humans, Immunoglobulins, Models, Genetic, Multiple Myeloma, Phenotype, Translocation, Genetic, Tumor Cells, Cultured, Gene Expression Regulation, Neoplastic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.